Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 200

Zhongneng United brings together investors for $167m

Huayun Financial Leasing has taken part in a $145m funding round for Zhongneng United, while Five Star supplied $21.8m in series B-plus capital.

Jul 31, 2019

PredictImmune foresees series B

PredictImmune, a Cambridge spinout, added series B capital from investors including Cambridge Enterprise and CIC to $6.1m in series A funding raised last April.

Jul 30, 2019

Corporates go through RedDoorz in $45m series B

MCN Group joined existing investor SIG in the hotel booking platform's series B round, which was co-led by Qiming Venture Partners and Jungle Ventures.

Jul 30, 2019

Sense recharges series B to reach $30m

Schneider Electric has been joined by Landis+Gyr, MKB and IDO Investments for a $10m series B extension that boosted the home energy monitoring platform's total funding to $50m.

Jul 30, 2019

Linkfin inks $50m series B

The big data and AI-powered automotive financing platform has secured funding in a round co-led by JD Digits and Tencent, which took part alongside Bertelsmann Asia Investments.

Jul 29, 2019

YY looks to play in Sandbox Network

The iDreamSky-backed online game development platform has raised $14.5m in a series B round that included strategic investor YY.

Jul 29, 2019

Balena calls in GE for series B

The Soracom and Ericsson-backed software development and management technology provider has raised $14.4m in a round that included General Electric unit GE Ventures.

Jul 29, 2019

Corporate venturing deal net: 22-26 July 2019

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Jul 26, 2019

TScan takes in $48m

Harvard Medical School spinout TScan has come out of stealth with $48m in funding provided by investors including GV and two Novartis units.

Jul 26, 2019

TScan takes in $48m

The Alphabet and Novartis-backed T cell cancer therapy developer has secured series B capital that took its overall funding to $48m.

Jul 26, 2019
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here